# FDA Inspection 874640 - Jeffrey S. Overcash, MD - April 14, 2014

Source: https://www.keypedia.com/records/fda_inspections/jeffrey-s-overcash-md/37d9015b-e084-4088-86fd-ae0d84532dea
Source feed: FDA_Inspections

> FDA Inspection 874640 for Jeffrey S. Overcash, MD on April 14, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 874640
- Company Name: Jeffrey S. Overcash, MD
- Inspection Date: 2014-04-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1223615 - 2023-11-17](https://www.keypedia.com/records/fda_inspections/jeffrey-s-overcash-md/a86f2307-c632-447c-8001-4e41c129a7d9)
- [FDA Inspection 1072272 - 2018-11-09](https://www.keypedia.com/records/fda_inspections/jeffrey-s-overcash-md/6ef23d9f-a395-4186-ad53-3a249c56d029)
- [FDA Inspection 1008933 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/jeffrey-s-overcash-md/db67b284-691b-4e7e-a6f1-caccd45c26c7)

Company: https://www.keypedia.com/companies/jeffrey-s-overcash-md/ac67a2af-442c-4f20-9b04-471344dadf99

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c